Please wait while the formulary information is being retrieved.
POKONZA (potassium chloride)
- low amount of potassium in the blood
- prevention of low potassium in the blood
10 mEq oral packet
- 1 packet (10 meq) dissolved in 120-240 ml of cold water by oral route 2 times per day
Default screening record
- 1 packet (10 meq) dissolved in 120-240 ml of cold water by oral route 2 times per day
- 1 packet (10 meq) dissolved in 120-240 ml of cold water by oral route 3 times per day
- 1 packet (10 meq) dissolved in 120-240 ml of cold water by oral route 4 times per day
- 1 packet (10 meq) dissolved in 120-240 ml of cold water by oral route once daily
- None
Contraindicated
- Aldactazide
- Aldactone
- amiloride
- amiloride-hydrochlorothiazide
- Dyazide
- Dyrenium
- eplerenone
- Inspra
- Kayexalate
- Kionex
- Marlexate
- Maxzide
- Maxzide-25Mg
- Sodium Polystyrene (sorb Free)
- sodium polystyrene sulfonate
- spironolacton-hydrochlorothiaz
- spironolactone
- Sps
- triamterene
- triamterene-hydrochlorothiazid
Severe
Moderate
- Accupril
- Accuretic
- Aceon
- Altace
- amlodipine-benazepril
- amlodipine-olmesartan
- amlodipine-valsartan
- amlodipine-valsartan-hcthiazid
- Angeliq
- Atacand
- Atacand Hct
- Avalide
- Avapro
- azilsartan med-chlorthalidone
- azilsartan medoxomil
- Azor
- benazepril
- benazepril-hydrochlorothiazide
- Benicar
- Benicar Hct
- Beyaz
- candesartan
- candesartan-hydrochlorothiazid
- captopril
- captopril-hydrochlorothiazide
- Cozaar
- Diovan Hct
- drospirenone-e.estradiol-lm.FA
- drospirenone-estradiol
- drospirenone-ethinyl estradiol
- Edarbi
- Edarbyclor
- enalapril maleate
- enalapril-hydrochlorothiazide
- enalaprilat
- Epaned
- eprosartan
- eprosartan-hydrochlorothiazide
- Exforge
- Exforge Hct
- fosinopril
- fosinopril-hydrochlorothiazide
- Gianvi (28)
- Hyzaar
- irbesartan
- irbesartan-hydrochlorothiazide
- lisinopril
- lisinopril-hydrochlorothiazide
- Loryna (28)
- losartan
- losartan-hydrochlorothiazide
- Lotensin
- Lotrel
- Mavik
- Micardis
- Micardis Hct
- moexipril
- moexipril-hydrochlorothiazide
- Ocella
- olmesartan
- olmesartan-amlodipin-hcthiazid
- olmesartan-hydrochlorothiazide
- perindopril erbumine
- Prinivil
- quinapril
- quinapril-hydrochlorothiazide
- ramipril
- Safyral
- Syeda
- Tarka
- telmisartan
- telmisartan-amlodipine
- telmisartan-hydrochlorothiazid
- Teveten
- Teveten Hct
- trandolapril
- trandolapril-verapamil
- Tribenzor
- Twynsta
- Uniretic
- Univasc
- valsartan-hydrochlorothiazide
- Vaseretic
- Vasotec
- Vestura (28)
- Yasmin (28)
- Yaz 28
- Zarah
- Zestoretic
- Zestril
- Familial hyperkalemic periodic paralysis
- Hyperkalemia
Contraindicated
- Anuria
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Complete atrioventricular block
- Dehydration
- Gastrointestinal ulcer
- Hyperchloremia
- Hyporeninemic hypoaldosteronism
- Myotonia congenita - autosomal dominant form
- Severe burns
- Severe heart block
Severe
Moderate
- Kidney disease with likely reduction in GFR
POKONZA (potassium chloride)
- low amount of potassium in the blood
- prevention of low potassium in the blood
- None
- Acute abdominal pain
- Diarrhea
- Flatulence
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Hyperkalemia
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bloody stools
- Duodenal ulcer
- Gastrointestinal hemorrhage
- Gastrointestinal irritation
- Gastrointestinal obstruction
- Gastrointestinal perforation
- Gastrointestinal ulcer
- Skin rash
- Sore throat
Less Severe
- None
Contraindicated
None
Severe Precaution
Potassium Chloride (tab, cap, pkt)
Dose form may be inappropriate for this age range.
- 1 Day – 364 Days
- Dose form may be inappropriate for this age range.
Management or Monitoring Precaution
None
Potassium Chloride (oral)
- Severity Level:
2
- Additional Notes: Insufficient human data available on developmental toxicity risk.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Potassium Salts (oral)
Renal-Decreased doses may be necessary in advanced renal dysfunction. Monitor serum potassium levels more closely. Gastrointestinal-Increased risk for gastritis.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Hypokalemia | |
| E87.6 | Hypokalemia |
| 0-9 | A-Z |
|---|---|
| E87.6 | Hypokalemia |
Formulary Reference Tool